Merck Sued For Securities Fraud Over Cholesterol Drug Trial
North Sound Capital LLC and two other institutional funds have sued Merck & Co. Inc. and its subsidiary for allegedly misrepresenting a crucial clinical study for its anti-cholesterol agents Zetia and...To view the full article, register now.
Already a subscriber? Click here to view full article